Testing effectiveness (Phase 2)Study completedNCT03965871
What this trial is testing
Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression
Who this might be right for
Bipolar Depression
Celon Pharma SA 88